Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012755 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Eleni Bilev und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. Hauptthemen laut MEDLINE: SARS-CoV-2, Killer Cells, Natural, COVID-19, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Stockholm, Cancerfonden, Insamlingsstiftelsen Cancer- och Allergifonden.
Abstract (Originalsprache)
In addition to adaptive immunity, natural killer (NK) cells of the innate immune system contribute to the control of viral infections. The HLA-E-restricted SARS-CoV-2 Nsp13 232-240 epitope VMPLSAPTL renders infected cells susceptible to NK cells by preventing binding to the inhibitory receptor NKG2A. Here, we report that a recently emerged methionine to isoleucine substitution at position 2 (pM2I) of Nsp13 232-240 impairs binding of the mutated epitope to HLA-E and diminishes HLA-E/peptide complex stability. Structural analyses revealed altered occupancy of the HLA-E B-pocket as the underlying cause for reduced presentation and stability of the mutated epitope. Functionally, the reduced presentation of the mutated epitope correlated with elevated binding to NKG2A as well as with increased NK cell inhibition. Moreover, the pM2I mutation associated with enhanced estimated viral fitness and was transmitted to descendants of the SARS-CoV-2 BQ.1 variant. Interestingly, the mutated epitope resembles sequences of related peptides found in endemic common cold-causing human coronaviruses. Altogether, these findings indicate compromised peptide presentation as a viral adaptation to evade NK cell-mediated immunosurveillance by enabling enhanced presentation of self-peptide and restoring NKG2A-dependent inhibition of NK cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
- Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Science for Life Laboratory, Department of Medicine Solna, Karolinska Institutet & Division of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden.
ORCID-Profile: Quirin Hammer
Förderung
- Region Stockholm
- Cancerfonden
- Insamlingsstiftelsen Cancer- och Allergifonden
- Vetenskapsrådet
- Åke Wiberg Stiftelse
- Karolinska Institutet
- Petrus och Augusta Hedlunds Stiftelse
- Stiftelsen Clas Groschinskys Minnesfond
Zitieren
APA
Bilev, E., Wild, N., Momayyezi, P., Sala, B. M., Sun, R., Sandalova, T., Marquardt, N., Ljunggren, H. G., Achour, A., & Hammer, Q. (2024). Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012755
Vancouver
Bilev E, Wild N, Momayyezi P, Sala BM, Sun R, Sandalova T, et al. Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012755
BibTeX
@article{Bilev2024,
author = {Bilev, Eleni and Wild, Nicole and Momayyezi, Pouria and Sala, Benedetta Maria and Sun, Renhua and Sandalova, Tatyana and Marquardt, Nicole and Ljunggren, Hans-Gustaf and Achour, Adnane and Hammer, Quirin},
title = {Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012755}
}
EUVIMED